vancomycin has been researched along with floxacillin in 46 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (19.57) | 18.7374 |
1990's | 7 (15.22) | 18.2507 |
2000's | 12 (26.09) | 29.6817 |
2010's | 10 (21.74) | 24.3611 |
2020's | 8 (17.39) | 2.80 |
Authors | Studies |
---|---|
Duewelhenke, N; Eysel, P; Krut, O | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Catherall, EJ; Irwin, R; Mizen, LW | 1 |
Hadderingh, RJ; Hulsebosch, HJ; Lange, JM; Reiss, P; van der Wouw, PA; Walford, N | 1 |
Berry, AJ; Ludlam, HA; Phillips, I; Young, AE | 1 |
Braveny, I; Machka, K; Milatovic, D | 1 |
Cohen, J; Ferreira, AC | 1 |
Guenthner, SH; Wenzel, RP | 1 |
Harvey, K; Pavillard, R | 1 |
Carmichael, A; Flanagan, PG | 1 |
Entenza, JM; Glauser, MP; Moreillon, P; Vouillamoz, J | 2 |
Degener, JE; Kosterink, JG; Mulder, JG | 1 |
Laycock, SL; Phoenix, DA; Wainwright, M; Wareing, DR; Wright, PA | 1 |
Blatter, M; Frei, R; Ochsner, PE; Widmer, AF; Zimmerli, W | 1 |
Dartnell, JG; Korman, TM; Robertson, MB | 1 |
Isaacs, D | 1 |
Balan, D; Li, Z; Nathwani, D; Rittenhouse, B; Vinken, A; Wilike, R | 1 |
Armstrong, MS; Cunningham, JL; Gheduzzi, S; Learmonth, ID; Miles, AW; Spencer, RF | 1 |
Loo, S; Mills, S; Muller, M; Upadhyay, V | 1 |
Bregenzer, T; Flueckiger, U; Francioli, P; Genné, D; Harbarth, S; Jacobs, F; Lew, DP; Petignat, C; Schockmel, G; Schrenzel, J; Zimmerli, W | 1 |
Catherall, EJ; Irwin, R; Mizen, L | 1 |
Daschner, F; Just, HM; Pinkawa, M; Rother, P | 1 |
Boyle, JR; Chaudhuri, A; Gaunt, ME; Hayes, PD; Sadat, U; Varty, K | 1 |
Ament, A; Broex, E; Deurenberg, RH; Gordts, B; Nulens, E; Scheres, J; Smeets, E; Stobberingh, EE; van Tiel, FH | 1 |
Malisano, L; Okamoto, K; Pelletier, MH; Smitham, PJ; Walsh, WR | 1 |
Barry, A; Fitzpatrick, F; Humphreys, H; McNicholas, S; Smyth, E | 1 |
Giebaly, DE; Horriat, S; Mangaleshkar, S; Sinha, A | 1 |
Bowler, IC; Buchanan, R; Crook, D; Stoesser, N | 1 |
Carr, JP; Diamond, Y; Freyne, B; Gwee, A | 1 |
Baird, R; Binks, P; Binks, PM; Brischetto, A; Coombs, G; Crowe, A; Dakh, F; Davis, J; Davis, JS; Davis, R; Ferguson, P; Ferguson, PE; Foo, H; Gordon, C; Howden, BP; Jeremiah, C; Kirby, A; Kirkwood, M; Leung, G; Liu, E; Majumdar, S; Menon, M; O'Sullivan, M; O'Sullivan, MVN; Owen, S; Pollet, S; Ralph, A; Ralph, AP; Robinson, JO; Robinson, O; Somerville, L; Subedi, S; Sud, A; Tong, S; Tong, SYC; Van Hal, S; van Hal, SJ; Whykes, K; Zhou, F | 1 |
Chew, R; Woods, ML | 1 |
Chatfield, M; Cheng, AC; Davis, JS; Fowler, VG; Howden, BP; Lipman, J; Lye, D; Nelson, J; O'Sullivan, M; Paterson, DL; Robinson, JO; Tong, SY; Van Hal, S; Yahav, D | 1 |
Callemeyn, J; Daenens, K; Derdelinckx, I; Dymarkowski, S; Fagard, K | 1 |
Gorman, M; McCann, M; McKeown, B | 1 |
Anagnostou, NA; Andresen, DN; Archuleta, S; Bak, N; Cass, A; Chatfield, MD; Cheng, AC; Davies, J; Davis, JS; Dotel, R; Ferguson, PE; Foo, H; Fowler, VG; Ghosh, N; Gray, TJ; Guy, SD; Holmes, NE; Howden, BP; Johnson, SA; Kalimuddin, S; Lye, DC; McBride, S; McKew, GL; Meagher, N; Nelson, J; O'Sullivan, MVN; Paterson, DL; Paul, M; Price, DJ; Ralph, AP; Roberts, MA; Robinson, JO; Rogers, BA; Runnegar, N; Smith, S; Sud, A; Tong, SYC; Tramontana, AR; van Hal, SJ; Walls, GB; Warner, MS; Yahav, D; Young, BE | 1 |
Blanch Sancho, JJ; García Aragonés, L; Martínez Alfaro, E; Mateos Rodriguez, F; Segura Luque, JC; Solís García Del Pozo, J | 1 |
Greisen, G; Gupta, M; Jakobsen, JC; Korang, SK; Lausten-Thomsen, U; Nava, C; Safi, S | 1 |
Falla, E; Mantopoulos, T; Nathwani, D; Vlachaki, I; Zinzi, D | 1 |
Croughs, PD; Lemmens-den Toom, NA; Sultan, AR; Tavakol, M; van Wamel, WJB; Verbon, A; Verkaik, NJ | 1 |
Bahmany, S; Barzel, I; Hunfeld, NGM; Jessurun, JG; Koch, BCP; van der Kuy, PHM | 1 |
Coleman, B; Kim, K; Munro, JT; Young, SW; Zhu, M | 1 |
Aiken, S; Boulton, Z; Brown, L; Delury, C; Fletcher, J; Knight, B; Michell, S; Porter, R; Romanczuk, L | 1 |
5 review(s) available for vancomycin and floxacillin
Article | Year |
---|---|
Methicillin resistance in Staphylococcus aureus with particular reference to Victorian strains.
Topics: Australia; beta-Lactamases; Cephalosporins; Drug Therapy, Combination; Floxacillin; Fusidic Acid; Humans; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1982 |
Flucloxacillin does not achieve therapeutic cerebrospinal fluid levels against meticillin-sensitive Staphylococcus aureus in adults: A case report and review of the literature.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Female; Floxacillin; Humans; Meningitis, Bacterial; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2016 |
Conservative treatment of non-aneurysmal infectious aortitis: a case report and review of the literature.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Aortitis; Contraindications, Procedure; Female; Floxacillin; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Ulcer; Vancomycin | 2019 |
What do beta-lactams add to vancomycin or daptomycin in the treatment of patients with methicillin-resistant
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cloxacillin; Daptomycin; Floxacillin; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2022 |
Antibiotic regimens for late-onset neonatal sepsis.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Aztreonam; Bias; Cefazolin; Clavulanic Acid; Drug Therapy, Combination; Floxacillin; Gentamicins; Humans; Infant, Newborn; Neonatal Sepsis; Randomized Controlled Trials as Topic; Ticarcillin; Vancomycin | 2021 |
5 trial(s) available for vancomycin and floxacillin
Article | Year |
---|---|
Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; Disease-Free Survival; Double-Blind Method; Drug Therapy, Combination; Female; Floxacillin; Hip Prosthesis; Humans; Knee Prosthesis; Male; Middle Aged; Orthopedic Fixation Devices; Penicillins; Prosthesis-Related Infections; Rifampin; Staphylococcal Infections; Treatment Outcome; Vancomycin | 1998 |
A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection.
Topics: Administration, Oral; Adult; Aged; Bacteremia; Catheters, Indwelling; Drug Therapy, Combination; Female; Fleroxacin; Floxacillin; Humans; Male; Methicillin Resistance; Middle Aged; Prospective Studies; Rifampin; Safety; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2004 |
Combination of Vancomycin and β-Lactam Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: A Pilot Multicenter Randomized Controlled Trial.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Bacteremia; Drug Therapy, Combination; Female; Floxacillin; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; New Zealand; Prospective Studies; Staphylococcal Infections; Time Factors; Treatment Outcome; Vancomycin; Young Adult | 2016 |
CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial.
Topics: Anti-Bacterial Agents; Australia; beta-Lactams; Cefazolin; Clinical Protocols; Cloxacillin; Daptomycin; Drug Therapy, Combination; Floxacillin; Humans; Israel; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; New Zealand; Research Design; Singapore; Staphylococcal Infections; Time Factors; Treatment Outcome; Vancomycin | 2016 |
Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cefazolin; Cloxacillin; Daptomycin; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Floxacillin; Follow-Up Studies; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Staphylococcal Infections; Treatment Failure; Vancomycin | 2020 |
36 other study(ies) available for vancomycin and floxacillin
Article | Year |
---|---|
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Antimycin A; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Chloramphenicol; Clindamycin; Dose-Response Relationship, Drug; Fluoroquinolones; Glycolysis; HeLa Cells; Humans; Lactic Acid; Linezolid; Macrolides; Mitochondria; Osteoblasts; Oxazolidinones; Rotenone; Tetracyclines; Time Factors | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Efficacy of amoxycillin/clavulanic acid in experimental Staphylococcus aureus endocarditis in the rat.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Clavulanic Acids; Drug Therapy, Combination; Endocarditis, Bacterial; Floxacillin; Male; Rats; Species Specificity; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Vancomycin | 1991 |
Disseminated cat-scratch disease in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Cat-Scratch Disease; Erythromycin; Floxacillin; Humans; Male; Opportunistic Infections; Vancomycin | 1989 |
The prevention of infection with Staphylococcus aureus in continuous ambulatory peritoneal dialysis.
Topics: Anti-Infective Agents, Local; Asepsis; Catheters, Indwelling; Chlorhexidine; Cross Infection; Female; Floxacillin; Humans; Male; Occlusive Dressings; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Staphylococcal Infections; Vancomycin; Wound Infection | 1989 |
Antibiotic treatment of streptococcal and staphylococcal endocarditis. Report of a working party of the British Society for Antimicrobial Chemotherapy.
Topics: Adult; Anti-Bacterial Agents; Drug Hypersensitivity; Endocarditis, Bacterial; Floxacillin; Gentamicins; Humans; Penicillin G; Penicillin Resistance; Penicillins; Staphylococcal Infections; Streptococcal Infections; Tooth Extraction; Vancomycin | 1985 |
In vitro interactions of carumonam in combination with coumermycin, teicoplanin, flucloxacillin and vancomycin.
Topics: Aminocoumarins; Anti-Bacterial Agents; Aztreonam; Bacteria; Cloxacillin; Coumarins; Drug Therapy, Combination; Enterobacter; Floxacillin; Glycopeptides; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Serratia marcescens; Teicoplanin; Vancomycin | 1987 |
Staphylococcus epidermidis endocarditis and mitral valve prolapse.
Topics: Adult; Endocarditis, Bacterial; Floxacillin; Fusidic Acid; Heart Valve Prosthesis; Humans; Male; Middle Aged; Mitral Valve; Mitral Valve Prolapse; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1988 |
In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Floxacillin; Fosfomycin; Fusidic Acid; Glycopeptides; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Staphylococcus aureus; Teicoplanin; Vancomycin | 1984 |
Endocarditis following skin procedures.
Topics: Dermatologic Surgical Procedures; Endocarditis, Bacterial; Floxacillin; Humans; Postoperative Complications; Vancomycin | 1993 |
Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Endocarditis, Bacterial; Floxacillin; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Rats; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1997 |
The relationship between the use of flucloxacillin, vancomycin, aminoglycosides and ciprofloxacin and the susceptibility patterns of coagulase-negative staphylococci recovered from blood cultures.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Ciprofloxacin; Coagulase; Drug Resistance, Microbial; Floxacillin; Humans; Microbial Sensitivity Tests; Penicillins; Sepsis; Streptococcal Infections; Streptococcus; Vancomycin | 1997 |
Photobactericidal activity of phenothiazinium dyes against methicillin-resistant strains of Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Azure Stains; Coloring Agents; Floxacillin; Humans; Light; Methicillin Resistance; Methylene Blue; Penicillins; Phenothiazines; Photosensitizing Agents; Staphylococcus aureus; Tolonium Chloride; Vancomycin | 1998 |
Vancomycin and teicoplanin use in Victorian hospitals. The Victorian Drug Usage Evaluation Group.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Child; Child, Preschool; Drug Utilization; Female; Floxacillin; Humans; Infant; Infant, Newborn; Infusions, Parenteral; Injections, Intravenous; Male; Middle Aged; Penicillin Resistance; Penicillins; Pharmacy Service, Hospital; Teicoplanin; Time Factors; Vancomycin; Victoria | 1999 |
Rationing antibiotic use in neonatal units.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Decision Making; Drug Resistance, Microbial; Floxacillin; Health Care Rationing; Humans; Infant, Newborn; Intensive Care, Neonatal; Penicillins; Sepsis; Vancomycin | 2000 |
Economic evaluation of linezolid, flucloxacillin and vancomycin in the empirical treatment of cellulitis in UK hospitals: a decision analytical model.
Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Cellulitis; Cost-Benefit Analysis; Decision Support Techniques; Decision Trees; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Utilization Review; Floxacillin; Gram-Positive Bacterial Infections; Hospital Costs; Hospitals, Public; Humans; Infection Control; Infusions, Intravenous; Linezolid; Oxazolidinones; Practice Patterns, Physicians'; United Kingdom; Vancomycin | 2001 |
Mechanical characteristics of antibiotic-laden bone cement.
Topics: Anti-Bacterial Agents; Bone Cements; Drug Interactions; Drug Therapy, Combination; Floxacillin; Gentamicins; Humans; In Vitro Techniques; Materials Testing; Penicillins; Polymethyl Methacrylate; Prosthesis-Related Infections; Stress, Mechanical; Tensile Strength; Vancomycin | 2002 |
Necrotising fasciitis in neonates: a multidisciplinary approach.
Topics: Anti-Bacterial Agents; Debridement; Fasciitis, Necrotizing; Female; Floxacillin; Humans; Infant, Newborn; Intensive Care, Neonatal; Male; Patient Care Team; Skin Transplantation; Staphylococcus aureus; Vancomycin | 2003 |
Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Endocarditis, Bacterial; Floxacillin; Fluoroquinolones; Infusions, Intravenous; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Rats; Staphylococcal Infections; Streptococcal Infections; Vancomycin; Viridans Streptococci | 2004 |
Comparative efficacy of amoxycillin + clavulanic acid (augmentin), flucloxacillin and vancomycin against S. aureus endocarditis in the rat.
Topics: Amoxicillin; Animals; Clavulanic Acid; Disease Models, Animal; Drug Therapy, Combination; Endocarditis, Bacterial; Floxacillin; Male; Rats; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1989 |
Bactericidal activity of flucloxacillin and vancomycin in broth, human serum, in the presence of polymorphonuclear leukocytes and on the influence of phagocytosis and intracellular killing against staphylococci.
Topics: Anti-Bacterial Agents; Floxacillin; Humans; Microbial Sensitivity Tests; Neutrophils; Phagocytosis; Staphylococcus; Staphylococcus epidermidis; Vancomycin | 1989 |
Five day antibiotic prophylaxis for major lower limb amputation reduces wound infection rates and the length of in-hospital stay.
Topics: Aged; Aged, 80 and over; Amputation, Surgical; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ciprofloxacin; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; England; Female; Floxacillin; Gentamicins; Humans; Length of Stay; Lower Extremity; Male; Medical Audit; Metronidazole; Middle Aged; Prospective Studies; Reoperation; Retrospective Studies; Surgical Wound Infection; Treatment Outcome; Vancomycin | 2008 |
Cost of the meticillin-resistant Staphylococcus aureus search and destroy policy in a Dutch university hospital.
Topics: Anti-Bacterial Agents; Bacteremia; Cost-Benefit Analysis; Cross Infection; Diagnostic Tests, Routine; Floxacillin; Health Care Costs; Health Policy; Hospitals, University; Humans; Infection Control; Methicillin Resistance; Netherlands; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2008 |
The compressive properties of bone cements containing large doses of antibiotics.
Topics: Anti-Bacterial Agents; Bone Cements; Compressive Strength; Drug Interactions; Floxacillin; Materials Testing; Methylmethacrylate; Polymethyl Methacrylate; Vancomycin | 2009 |
Audit of the management of Staphylococcus aureus bloodstream infection: gaps to be plugged.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Female; Floxacillin; Humans; Male; Medical Audit; Methicillin; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Young Adult | 2010 |
Pyomyositis of the piriformis muscle presenting with sciatica in a teenage rugby player.
Topics: Abscess; Adolescent; Anti-Bacterial Agents; Floxacillin; Football; Humans; Low Back Pain; Magnetic Resonance Imaging; Male; Meropenem; Pain; Piriformis Muscle Syndrome; Pyomyositis; Rifampin; Sciatica; Staphylococcal Infections; Staphylococcus aureus; Thienamycins; Vancomycin | 2012 |
Multidrug-resistant Escherichia coli soft tissue infection investigated with bacterial whole genome sequencing.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Diagnosis, Differential; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Floxacillin; Follow-Up Studies; Genome, Bacterial; Gentamicins; Humans; Liver Diseases; Male; Meropenem; Middle Aged; Sequence Analysis, DNA; Soft Tissue Infections; Thienamycins; Treatment Outcome; Vancomycin | 2014 |
Brain Abscess Due to Staphylococcus lugdunenis: A CoNSiderable Pathogen.
Topics: Brain Abscess; Ceftriaxone; Cerebellum; Child, Preschool; Coinfection; Dermoid Cyst; Drainage; Female; Floxacillin; Humans; Magnetic Resonance Imaging; Staphylococcal Infections; Staphylococcus; Teicoplanin; Treatment Outcome; Vancomycin | 2015 |
No Fever, No Murmur, No Problem? A Concealed Case of Infective Endocarditis.
Topics: Adult; Amphetamine; Analgesics, Opioid; Anti-Bacterial Agents; C-Reactive Protein; Endocarditis; Enoxaparin; Female; Fentanyl; Floxacillin; Gentamicins; Humans; Inflammation; Leg; Methicillin-Resistant Staphylococcus aureus; Oxycodone; Pain; Substance-Related Disorders; Vancomycin | 2019 |
Cost-minimisation analysis of oritavancin for the treatment of acute bacterial skin and skin structure infections from a United Kingdom perspective.
Topics: Anti-Bacterial Agents; Daptomycin; Floxacillin; Glycopeptides; Humans; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Quality of Life; State Medicine; Teicoplanin; Vancomycin | 2022 |
Real time monitoring of Staphylococcus aureus biofilm sensitivity towards antibiotics with isothermal microcalorimetry.
Topics: Anti-Bacterial Agents; Biofilms; Calorimetry; Floxacillin; Genetic Linkage; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rifampin; Staphylococcus aureus; Vancomycin | 2022 |
Evaluation of the importance of mixing during preparation of antibiotic infusions.
Topics: Anti-Bacterial Agents; Cefuroxime; Floxacillin; Infusions, Intravenous; Meropenem; Vancomycin | 2022 |
Differing Microorganism Profile in Early and Late Prosthetic Joint Infections Following Primary Total Knee Arthroplasty - Implications for Empiric Antibiotic Treatment.
Topics: Anti-Bacterial Agents; Arthritis, Infectious; Arthroplasty, Replacement, Knee; Floxacillin; Hip Prosthesis; Humans; Knee Prosthesis; Prosthesis-Related Infections; Retrospective Studies; Vancomycin | 2022 |
Topics: Agar; Anti-Bacterial Agents; Bacteria; Calcium Sulfate; Diabetes Mellitus; Diabetic Foot; Floxacillin; Gentamicins; Humans; Microbial Sensitivity Tests; Rifampin; Vancomycin | 2022 |